COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA: A SYSTEMS BIOLOGY PERSPECTIVE ON THE SYNERGISTIC ANTITUMOR ACTIVITY OF SORAFENIB WITH PI3K/AKT PATHWAY INHIBITORS


Ersahin T., TUNÇBAĞ N., ACAR A. F. , Cetin-Atalay R.

50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, Avusturya, 22 - 26 Nisan 2015, cilt.62 identifier